Review of the Epidemiology, Diagnosis and Management of Invasive Meningococcal Disease in Vietnam

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2023 Mar 23

PMID 36951161

Authors

Phung Nguyen The Nguyen

Nguyen Thanh Hung

Gaurav Mathur

Thatiana de Jesus Pereira Pinto

Nguyen Hoan Le Minh

Affiliations

Soon will be listed here.

Abstract

Invasive meningococcal disease (IMD), caused by , is life-threatening with a high case fatality rate (CFR) and severe sequelae. We compiled and critically discussed the evidence on IMD epidemiology, antibiotic resistance and disease management in Vietnam, focusing on children. PubMed, Embase and gray literature searches for English, Vietnamese and French publications, with no date restrictions, retrieved 11 eligible studies. IMD incidence rate (/100,000 population) was 7.4 [95% confidence interval 3.6-15.3] in children under 5 years of age; driven by high rates in infants (e.g. 29.1 [8.0-106.0] in 7-11 month-olds). Serogroup B IMD was predominant. strains may have developed resistance to streptomycin, sulfonamides, ciprofloxacin, and possibly ceftriaxone. There was a lack of current data on diagnosis and treatment of IMD, which remain challenging. Healthcare professionals should be trained to rapidly recognize and treat IMD. Preventive measures, such as routine vaccination, could help address the medical need.

Citing Articles

A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine.

Kim Y, Bae S, Yu K, Lee S, Lee C, Kim J NPJ Vaccines. 2024; 9(1):140.

PMID: 39112515 PMC: 11306796. DOI: 10.1038/s41541-024-00935-8.

An isothermal CRISPR- based lateral flow assay for detection of Neisseria meningitidis.

Huyen D, Reboud J, Quyen D, Cooper J, Velavan T, Trung N Ann Clin Microbiol Antimicrob. 2024; 23(1):28.

PMID: 38555443 PMC: 10981803. DOI: 10.1186/s12941-024-00688-1.

4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion.

Nguyen P, Thai P, Dien T, Hai D, Thi Trang Dai V, Luan N Infect Dis Ther. 2024; 13(3):423-437.

PMID: 38430327 PMC: 10965853. DOI: 10.1007/s40121-023-00905-y.

References

Galimand M, Gerbaud G, Guibourdenche M, Riou J, Courvalin P . High-level chloramphenicol resistance in Neisseria meningitidis. N Engl J Med. 1998; 339(13):868-74. DOI: 10.1056/NEJM199809243391302. View

Paireau J, Chen A, Broutin H, Grenfell B, Basta N . Seasonal dynamics of bacterial meningitis: a time-series analysis. Lancet Glob Health. 2016; 4(6):e370-7. PMC: 5516123. DOI: 10.1016/S2214-109X(16)30064-X. View

Haj-Hassan T, Thompson M, Mayon-White R, Ninis N, Harnden A, Smith L . Which early 'red flag' symptoms identify children with meningococcal disease in primary care?. Br J Gen Pract. 2011; 61(584):e97-104. PMC: 3047346. DOI: 10.3399/bjgp11X561131. View

Tran T, Le T, Trieu L, Austin C, Quyen D, Nguyen H . Whole-genome sequencing and characterization of an antibiotic resistant Neisseria meningitidis B isolate from a military unit in Vietnam. Ann Clin Microbiol Antimicrob. 2019; 18(1):16. PMC: 6501280. DOI: 10.1186/s12941-019-0315-z. View

Van C, Nguyen T, Bui S, Nguyen T, Tran H, Pham D . Invasive Meningococcal Disease Remains a Health Threat in Vietnam People's Army. Infect Drug Resist. 2021; 14:5261-5269. PMC: 8667609. DOI: 10.2147/IDR.S339110. View

Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H . Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis. Vaccine. 2019; 37(21):2768-2782. DOI: 10.1016/j.vaccine.2019.04.020. View

Olcen P, Fredlund H . Isolation, culture, and identification of meningococci from clinical specimens. Methods Mol Med. 2011; 67:9-21. DOI: 10.1385/1-59259-149-3:9. View

Hollingshead S, Tang C . An Overview of Neisseria meningitidis. Methods Mol Biol. 2019; 1969:1-16. DOI: 10.1007/978-1-4939-9202-7_1. View

Marchetti F, Prato R, Viale P . Survey among Italian experts on existing vaccines' role in limiting antibiotic resistance. Hum Vaccin Immunother. 2021; 17(11):4283-4290. PMC: 8828092. DOI: 10.1080/21645515.2021.1969853. View

10.

Martinon-Torres F . Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements. J Adolesc Health. 2016; 59(2 Suppl):S12-20. DOI: 10.1016/j.jadohealth.2016.03.041. View

11.

Hovmand N, Christensen H, Lundbo L, Sandholdt H, Kronborg G, Darso P . Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease. BMC Fam Pract. 2021; 22(1):240. PMC: 8630890. DOI: 10.1186/s12875-021-01585-8. View

12.

Panatto D, Amicizia D, Lai P, Cristina M, Domnich A, Gasparini R . New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers. Indian J Med Res. 2014; 138(6):835-46. PMC: 3978970. View

13.

Batty E, Cusack T, Thaipadungpanit J, Watthanaworawit W, Carrara V, Sihalath S . The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia. Int J Infect Dis. 2020; 95:198-203. PMC: 7294222. DOI: 10.1016/j.ijid.2020.03.081. View

14.

Thisyakorn U, Carlos J, Chotpitayasunondh T, Dien T, Gonzales M, Huong N . Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies. Hum Vaccin Immunother. 2022; 18(6):2110759. PMC: 9746482. DOI: 10.1080/21645515.2022.2110759. View

15.

Cabellos C, Pelegrin I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D . Invasive Meningococcal Disease: What We Should Know, Before It Comes Back. Open Forum Infect Dis. 2019; 6(3):ofz059. PMC: 6440684. DOI: 10.1093/ofid/ofz059. View

16.

Pelton S . The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines. J Adolesc Health. 2016; 59(2 Suppl):S3-S11. DOI: 10.1016/j.jadohealth.2016.04.012. View

17.

White C, Scott J . Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go?. Can J Public Health. 2010; 101(1):12-4. PMC: 6973578. View

18.

Kim S, Kim D, Dong B, Kim J, Anh D, Kilgore P . An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia. BMC Infect Dis. 2012; 12:310. PMC: 3519641. DOI: 10.1186/1471-2334-12-310. View

19.

Thompson M, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L . Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006; 367(9508):397-403. DOI: 10.1016/S0140-6736(06)67932-4. View

20.

Aye A, Bai X, Borrow R, Bory S, Carlos J, Caugant D . Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative. J Infect. 2020; 81(5):698-711. DOI: 10.1016/j.jinf.2020.07.025. View